期刊文献+

腹膜透析相关腹膜炎的病原菌耐药性分析 被引量:5

Distribution and drug resistance of pathogens isolated from patients with peritoneal dialysis-related peritonitis
原文传递
导出
摘要 目的分析腹膜透析相关腹膜炎的病原菌及其耐药性特点,以期指导临床合理使用抗菌药物。方法回顾性分析2007年1月-2016年12月在复旦大学附属华山医院就诊的腹透相关性腹膜炎病例,统计患者的病原菌分布及其耐药性。结果对203例次腹透相关性腹膜炎患者的送检标本进行细菌培养,检出病原菌160株,其中革兰阳性菌95株占59.4%,革兰阴性菌62株占38.8%,真菌3株占1.8%;革兰阳性菌中凝固酶阴性葡萄球菌对青霉素的耐药率较高,为81.1%,酿脓链球菌的耐药率较低,革兰阴性菌中大肠埃希菌对阿米卡星、环丙沙星耐药率较低,分别为8.3%、25.8%,而对氨苄西林、哌拉西林等耐药率均较高,分别为81.8%、45.2%。结论腹膜透析相关性腹膜炎致病菌以革兰阳性菌为主,推荐万古霉素、利奈唑胺或利福平作为革兰阳性菌腹膜炎的经验用药;革兰阴性菌对庆大霉素、环丙沙星耐药率较低,故可作为首选经验性用药,同时,在培养结果出来后应根据药敏结果及时调整用药。 OBJECTIVE To investigate the distribution and drug resistance of pathogens isolated from patients with peritoneal dialysis-related peritonitis so as to provide guidance for reasonable clinical use of antibiotics.METHODS The patients with peritoneal dialysis-related peritonitis who were treated in Huashan Hospital of Fudan University from Jan 2007 to Dec 2016 were retrospectively analyzed.The distribution and drug resistance of the pathogens isolated from the patients were statistically analyzed.RESULTS The bacterial culture was carried out for submitted specimens that were obtained from 203 case-times of patients with peritoneal dialysis-related peritonitis.A total of 160 strains of pathogens were isolated,of which 59.4%(95 strains)were gram-positive bacteria,38.8%(62 strains)were gram-negative bacteria,and 1.8%(3 strains)were fungi.Among the gram-positive bacteria,the drug resistance rate of coagulase-negative Staphylococcus strains to penicillin was 81.1%,and the drug resistance rate of Streptococcus pyogenes strains was low.Among the gram-negative bacteria,the drug resistance rates of Escherichia coli strains to amikacin and ciprofloxacin were 8.3%and 25.8%,respectively,while the drug resistance rates to ampicillin and piperacillin were 81.8%and 45.2%,respectively.CONCLUSION The gram-positive bacteria are dominant among the pathogens causing the peritoneal dialysis-related peritonitis,and vancomycin,linezolid or rifampicin is recommended for empirical drug therapy fro treatment of peritonitis caused by the gram-positive bacteria.The gram-negative bacteria are highly susceptible to gentamicin and ciprofloxacin,which should be preferred for the empirical drug therapy,and it is necessary to adjust the medication on the basis of the result of drug susceptibility testing after the bacterial culture.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2017年第17期3905-3908,共4页 Chinese Journal of Nosocomiology
关键词 腹膜透析 腹膜炎 病原菌 耐药性 Peritoneal dialysis Peritonitis Pathogen Drug resistance
  • 相关文献

参考文献3

二级参考文献47

  • 1陈林,郭群英,阳晓,姜宗培,陈崴,毛海萍,余学清.腹膜透析相关性真菌性腹膜炎20例临床分析[J].中国血液净化,2006,5(10):710-713. 被引量:18
  • 2郭群英,陈林,阳晓,杨念生,冯敏,姜宗培,毛海萍,陈崴,余学清.腹膜透析相关感染性腹膜炎致病菌及菌谱变化——单个腹膜透析中心15年回顾分析[J].中华肾脏病杂志,2006,22(12):719-724. 被引量:64
  • 3倪军,童孟立,崔杏成.72例次持续性非卧床腹透腹膜炎分析[J].中国中西医结合肾病杂志,2007,8(4):217-219. 被引量:24
  • 4Bender FH,Bernardini J,Piraino B. Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int, (Suppl) 2006,103:44 - 54.
  • 5Keane WF, Bailie GR, Boeschoten E,et al. Adult peritoneal dialysisrelated peritonitis treatment recommendations: 2000 update. Petit Dial Int ,2000,20 : 396 -411.
  • 6Piraino B, Baille GR, Bernardini J, et al. Peritoneal dialysis related infections recommendations: 2005 update. Perit Dial Int, 2005,25 (2): 107 - 131.
  • 7Furgeson SB ,Teitelbaum L New Treatment Options and Protocols for Peritoneal Dialysis-Related Peritonitis. Contrib Nephrol, 2009,163 : 169 - 176.
  • 8Kan GW,Thomas MA, Heath CH. A 12-month rewiew of peritoneal dialysis-related peritonitis in western australia:Is empiric vancomnycin still indicated for some patients? Petit Dial Int,2003,23: 465 -468.
  • 9Kabat-Koperska J, Col embiewska E, Ciechanowski K. Peritoneal dialysis-related peritonitis in the years 2005-2007 among patients of the Peritoneal Dialysis Clinic of the Department of Neparology, Transplantology and Internal Medicine, Pmneranian Medical University in Szczecin. Pol Arch Med Wewn,2008,118(12) : 694 -699.
  • 10Lima RC, Barreira A, Cardoso FL, et al. Ciprofloxaein and eefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis:five-year follow-up. Perit Dial Int,2007,27( 1 ) : 56 -60.

共引文献57

同被引文献57

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部